International Aldosterone Conference - Cardiovascular
国际醛固酮会议 - 心血管
基本信息
- 批准号:8130434
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenal CortexAdrenergic AgonistsAldosteroneAngiotensin IIAngiotensin-Converting Enzyme InhibitorsAnimalsBiochemistryBlood VesselsCardiac MyocytesCardiovascular DiseasesCardiovascular systemCaveolinsCellsClinical TrialsConflict (Psychology)CorticotropinDataDevelopmentDiabetes MellitusDisciplineDiseaseEndocrinologistEndothelial CellsEndothelinEpithelial CellsExperimental ModelsExplosionFloodsFosteringFunctional disorderGeneticGrowthHealthHeart DiseasesHomeostasisHumanHyperaldosteronismHypertensionIndividualInternationalKidneyLysineMediatingMetabolic syndromeMineralocorticoid ReceptorModelingMolecularMolecular and Cellular BiologyMononuclearNatriuretic PeptidesNeuronsObesityOutcomePathway interactionsPatternPhysiologyPotassiumReceptor ActivationRegulationResearch PersonnelRoleScienceSeriesSleep Apnea SyndromesSmooth Muscle MyocytesStrokeSystemTherapeutic Human ExperimentationTimecardiovascular injurycardiovascular risk factorcareermeetingspreventprogramsrapid growthreceptorskillssymposiumvascular inflammation
项目摘要
DESCRIPTION (provided by applicant): We are requesting support for a series of annual conferences from 2011 - 2015 to be called the International Aldosterone Conference-Cardiovascular. The objective of these conferences is to expand the understanding of the science - from cells to humans - underlying the role of aldosterone and mineralocorticoid receptor activation in increasing cardiovascular risk across a broad range of cardiovascular diseases, e.g., hypertension, diabetes mellitus, obesity, sleep apnea, metabolic syndrome, heart disease, stroke and renal dysfunction. This objective will be accomplished by using the approach and format of the International Aldosterone Conference. This approach has been successful in the past to accomplish a similar objective directed at the mechanism of activation of the mineralocorticoid receptor in epithelial cells, e.g., in the kidney. The format consists of an annual meeting for five years. Each annual meeting will consist of three half-day sessions. Each session begins with a state-of-the-art speaker who is an expert in a specific discipline related to aldosterone but who is not per se and expert in aldosterone. The attendees are experts and researchers in aldosterone/mineralocorticoid receptor physiology, pathophysiology, clinical trials, biochemistry, molecular and cellular biology and genetics. Young investigators in the field are encouraged to attend. The outcome from this series of conferences will be better understanding of the factors underlying the adverse cardiovascular effects produced by an activated aldosterone/mineralocorticoid receptor system. With this increased understanding will come better approaches to prevent and/or treat cardiovascular diseases.
描述(由申请人提供):我们要求为2011年至2015年的一系列年度会议提供支持,称为国际醛固酮会议 - 钟血管。这些会议的目的是扩展对科学的理解 - 从细胞到人 - 醛固酮和矿物皮质激活受体激活在多种心血管疾病中增加心血管风险增加的作用,例如高血压,高血压,糖尿病,糖尿病,糖尿病,肥胖,肥胖,睡眠apnea apnea,prenea,pren疾病,培养基,内定位疾病和心脏,心脏,心脏,疾病,疾病,疾病,疾病,疾病,疾病。该目标将通过使用国际醛固酮会议的方法和格式来实现。过去,这种方法已经成功地完成了一个针对上皮细胞中矿物皮质激素受体激活机制的类似物体,例如在肾脏中。该格式由五年的年度会议组成。每个年度会议将包括三个半天会议。每个会议始于一位最先进的演讲者,他是与醛固酮有关的特定学科专家,但不是本身本身和醛固酮专家。与会者是醛固酮/矿物皮质受体生理学,病理生理学,临床试验,生物化学,分子和细胞生物学和遗传学的专家和研究人员。鼓励该领域的年轻调查员参加。这一系列会议的结果将更好地理解激活的醛固酮/矿物皮质激活受体系统产生的不良心血管效应的因素。随着这种理解,将出现更好的方法来预防和/或治疗心血管疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GORDON H WILLIAMS其他文献
GORDON H WILLIAMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GORDON H WILLIAMS', 18)}}的其他基金
Aldosterone, Histone Demethylase and Cardiovascular Disease
醛固酮、组蛋白去甲基化酶与心血管疾病
- 批准号:
7923955 - 财政年份:2009
- 资助金额:
$ 1.5万 - 项目类别:
Aldosterone, Histone Demethylase and Cardiovascular Disease
醛固酮、组蛋白去甲基化酶与心血管疾病
- 批准号:
7737103 - 财政年份:2009
- 资助金额:
$ 1.5万 - 项目类别:
THE EFFECTS OF MIDODRINE ON ORTHOSTATIC TOLERANCE IN WOMEN
米多君对女性直立耐受性的影响
- 批准号:
7719347 - 财政年份:2008
- 资助金额:
$ 1.5万 - 项目类别:
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES
糖尿病血管功能障碍:基因和激素
- 批准号:
7719303 - 财政年份:2008
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
水体中β2-肾上腺素受体激动剂(PPCPs)间接光降解机理的量子化学与实验研究
- 批准号:22306084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:82273909
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β3肾上腺素受体激动剂对小鼠肩袖延迟修复后肌肉脂肪浸润的治疗作用及机制研究
- 批准号:81902245
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Peripheral Vasoconstriction in Heart Failure: Mechanisms & Modulatory Influences
心力衰竭的周围血管收缩:机制
- 批准号:
8996194 - 财政年份:2014
- 资助金额:
$ 1.5万 - 项目类别:
Peripheral Vasoconstriction in Heart Failure: Mechanisms & Modulatory Influences
心力衰竭的周围血管收缩:机制
- 批准号:
8632342 - 财政年份:2014
- 资助金额:
$ 1.5万 - 项目类别:
Peripheral Vasoconstriction in Heart Failure: Mechanisms & Modulatory Influences
心力衰竭的周围血管收缩:机制
- 批准号:
9417951 - 财政年份:2014
- 资助金额:
$ 1.5万 - 项目类别: